Iconiq Innovation Ltd is a privately held ltd company established in Leicester, UK, on July 19th, 2010. Currently active and regulated under registration number 07318486, the firm specializes in research and experimental development within natural sciences and engineering disciplines. The company's core business revolves around providing bespoke solutions through dedicated scientific exploration and innovative project execution. Over five years, Iconiq Innovation has cultivated a substantial portfolio of €150 million+ in revenue generated from client partnerships across various sectors. Specifically, the firm’s expertise encompasses a broad range of natural sciences including chemistry, materials science, and biology – alongside engineering applications. They operate within SIC codes related to other research and experimental development on natural sciences and engineering; this includes but is not limited to: pharmaceuticals, biotechnology, and advanced material synthesis. The company has a significant international presence, demonstrating a global reach through strategic collaborations and client relationships. The firm employs a team of skilled specialists dedicated to tackling complex challenges using cutting-edge technology and scientific methodologies.

Iconiq Innovation Ltd is a privately held ltd company established in Leicester, UK, on July 19th, 2010. Currently active and regulated under registration number 07318486, the firm specializes in research and experimental development within natural sciences and engineering disciplines. The company's core business revolves around providing bespoke solutions through dedicated scientific exploration and innovative project execution. Over five years, Iconiq Innovation has cultivated a substantial portfolio of €150 million+ in revenue generated from client partnerships across various sectors. Specifically, the firm’s expertise encompasses a broad range of natural sciences including chemistry, materials science, and biology – alongside engineering applications. They operate within SIC codes related to other research and experimental development on natural sciences and engineering; this includes but is not limited to: pharmaceuticals, biotechnology, and advanced material synthesis. The company has a significant international presence, demonstrating a global reach through strategic collaborations and client relationships. The firm employs a team of skilled specialists dedicated to tackling complex challenges using cutting-edge technology and scientific methodologies.